WallStSmart

Marex Group plc Ordinary Shares (MRX)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 66721% more annual revenue ($2.33T vs $3.49B). NMR leads profitability with a 17.3% profit margin vs 12.2%. NMR trades at a lower P/E of 12.8x. NMR earns a higher WallStSmart Score of 84/100 (A-).

MRX

Strong Buy

72

out of 100

Grade: B

Growth: 10.0Profit: 7.0Value: 6.0Quality: 3.8
Piotroski: 3/9Altman Z: 0.86

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MRX4 strengths · Avg: 9.3/10
Revenue GrowthGrowth
32.1%10/10

Revenue surging 32.1% year-over-year

EPS GrowthGrowth
105.3%10/10

Earnings expanding 105.3% YoY

Return on EquityProfitability
29.1%9/10

Every $100 of equity generates 29 in profit

P/E RatioValuation
15.6x8/10

Attractively priced relative to earnings

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

Areas to Watch

MRX3 concerns · Avg: 2.7/10
Debt/EquityHealth
1.513/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
0.862/10

Distress zone — elevated risk

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MRX

The strongest argument for MRX centers on Revenue Growth, EPS Growth, Return on Equity. Revenue growth of 32.1% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bear Case : MRX

The primary concerns for MRX are Debt/Equity, Piotroski F-Score, Altman Z-Score. Debt-to-equity of 1.51 is elevated, increasing financial risk.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Key Dynamics to Monitor

NMR carries more volatility with a beta of 0.61 — expect wider price swings.

MRX is growing revenue faster at 32.1% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 72/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Marex Group plc Ordinary Shares

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Marex Group plc is a premier global commodities brokerage and risk management firm, specializing in comprehensive trading, clearing, and advisory services across essential sectors such as metals, energy, and agricultural commodities. With a robust technological infrastructure and deep market expertise, Marex provides customized solutions to a diverse clientele, including multinational corporations, financial institutions, and hedge funds. As a publicly traded entity, the company is dedicated to operational excellence and seeks to enhance its competitive edge in the commodities trading landscape while delivering sustainable value to its shareholders.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?